导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 35.36% | 10/76 |
| 近一周 | -3.65% | 58/84 |
| 近一月 | -4.89% | 50/85 |
| 近一季 | -14.64% | 73/85 |
| 近半年 | 29.81% | 11/78 |
| 近一年 | 46.41% | 8/74 |
| 近两年 | 86.65% | 14/70 |
| 近三年 | 129.75% | 9/62 |
| 成立以来 | 163.03% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.46% 21/76 |
72.79% 9/85 |
- - |
- - |
| 2025 | 22.49% 38/76 |
-13.58% 69/74 |
20.64% 11/74 |
11.34% 50/74 |
5.53% 10/76 |
| 2024 | 28.71% 9/75 |
12.52% 5/67 |
6.90% 25/72 |
-1.59% 63/74 |
8.74% 7/75 |
| 2023 | 40.58% 3/72 |
12.69% 3/57 |
16.04% 10/64 |
-5.49% 41/68 |
13.75% 8/72 |
| 2022 | -31.64% 38/46 |
-13.65% 29/43 |
-17.72% 40/45 |
1.44% 4/45 |
-5.14% 38/46 |
| 2021 | 6.54% 12/43 |
0.38% 192/312 |
4.52% 141/328 |
-2.24% 164/358 |
3.87% 9/43 |
| 2020 | 35.21% 16/41 |
-11.44% 141/280 |
28.97% 44/295 |
9.46% 53/299 |
8.15% 151/305 |
| 2019 | - - |
- - |
4.55% 43/268 |
0.24% 139/253 |
8.74% 89/266 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 平安港股医疗优选股票(QDII)A | 0.9556 | 19.76% |
| 平安港股医疗优选股票(QDII)C | 0.9520 | 18.70% |
| 诺安油气能源 | 1.4510 | 13.79% |
| 创金合信全球医药生物股票发起(QDII)A | 1.5491 | 9.61% |
| 创金合信全球医药生物股票发起(QDII)C | 1.5285 | 9.47% |
| 宏利印度股票(QDII) | 1.3394 | 3.49% |
| 宏利印度股票(QDII)C | 1.3360 | 3.41% |
| 长城港股价值优选股票(QDII)A | 0.9773 | 1.91% |
| 长城港股价值优选股票(QDII)C | 0.9755 | 1.82% |
| 华宝海外科技股票(QDII-LOF)A | 2.3598 | 1.69% |
| 浦银安盛全球智能科技(QDII)A VS. 华宝海外科技股票(QDII(501312) |